Onward, a Fundrise Production

57: This miracle pill could make dogs live longer, with Celine Halioua, Founder & CEO of Loyal

May 21, 2026

What if the biggest barrier to a longer life isn't science, but the economic incentives of corporations? In this episode of Onward, Ben sits down with Celine Halioua, founder and CEO of Loyal — the biotech company on track to earn the first-ever FDA approval for a drug whose only purpose is to extend lifespan. The catch: they're starting with dogs.Celine walks Ben through why the U.S. healthcare system is structurally incapable of building preventative medicine, why each dog-owner relationshi...

56: Will AI do your job? with Raza Habib, Member of Technical Staff at Anthropic

March 25, 2026

Raza Habib, Member of Technical Staff at Anthropic (creators of Claude and Claude Code) unpacks what “Artificial General Intelligence” even means, why the pace of AI progress still looks steep, and what that implies for jobs, companies, and public policy. Raza shares how his own “AGI probability” evolved from PhD-era skepticism to today’s conviction that we’re on a transformative trajectory. —For a deeper dive into these insights and more, be sure to listen to the full episode of the Onward p...

55: IPO Roadshow: VCX is the public ticker for private tech

February 20, 2026

IPO Roadshow: VCX is the public ticker for private techThe number of public companies has been cut in half over the past 25 years. The best private companies are staying private longer than ever. As a result, ordinary investors have been locked out of the biggest wealth-creation opportunities of this generation. With AI threatening to drive wealth inequality to new levels, Ben calls this a fairness problem as much as a financial one.His answer: take the Fundrise Innovation Fund public under t...